The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 06, 2026
Snapshot (as of Sep 06, 2026): AstraZeneca PLC (AZN) pays a $3.23 annual dividend ($0.81 quarterly), yielding 1.99% at $162.70/share. Next ex-dividend date 2026-08-07. 9 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.99%
Annual Dividend: $3.23 per share
Payout Ratio: 47.0%
Ex-Dividend Date: 2026-08-07
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 34
AstraZeneca PLC dividend income comes from one of the world's largest biopharmaceutical companies, with a portfolio spanning oncology, cardiovascular, and rare disease treatments. The current yield stands at 1.99%, with a trailing annual dividend rate of $3.2303 per share paid quarterly. The next ex-dividend date is August 7, 2026. AZN's beta of 0.211 points to low price volatility, which suits income investors who prioritize capital preservation over high yield.
AstraZeneca PLC pays out 47.0% of earnings as dividends, a payout ratio classified as moderate (40–60%). That level leaves meaningful earnings headroom, supported by a broad portfolio of prescription medicines including Tagrisso, Farxiga, and Soliris, which address conditions with recurring treatment demand across cardiovascular, oncological, and rare disease categories. AstraZeneca PLC dividend safety faces its most visible pressure from the R&D-intensive nature of drug development, where pipeline failures or patent expirations can erode the earnings base that currently supports the payout.
AstraZeneca PLC dividend history shows a CAGR of -1.8% per year from 2009 to 2025. Per-share payments moved from $2.0900 in 2009 to $1.5650 in 2025 (2026 is a partial year and excluded from this calculation). The largest annual increase in the window was 15.3% in 2010, but the history also contains at least one year-over-year decline exceeding 5%, and the overall trend across the full window is negative. Growth is slow, and the long-run direction has worked against income investors seeking rising payouts.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +3.3% | $1.42 (2022) | $1.56 (2025) |
| 5-Year | +2.4% | $1.39 (2020) | $1.56 (2025) |
| 10-Year | -4.0% | $2.35 (2015) | $1.56 (2025) |
AstraZeneca PLC stock fits dividend investors who value low price volatility over high or fast-growing income. The yield of 1.99% is classified as low (below 2%), and the 5-year average yield of 0.9% shows the current yield is well above that historical norm, which reflects either a higher payout or a lower share price relative to recent years. Nine consecutive years of dividend increases is a positive signal, but the full history from 2009 to 2025 shows a negative CAGR of -1.8%. The trade-off is clear: AZN offers a low-volatility biopharmaceutical holding with a moderate payout ratio, but income investors accept limited dividend growth and a below-average yield.
| Payment Date | Amount per Share |
|---|---|
| 2026-08-07 | $1.0600 |
| 2026-02-20 | $2.1700 |
| 2025-08-08 | $0.5150 |
| 2025-02-21 | $1.0500 |
| 2024-08-09 | $0.5000 |
| 2024-02-22 | $0.9850 |
| 2023-08-10 | $0.4650 |
| 2023-02-23 | $0.9650 |
| 2022-08-11 | $0.4550 |
| 2022-02-24 | $0.9650 |
| Year | Total Dividends |
|---|---|
| 2026 | $3.2300 |
| 2025 | $1.5650 |
| 2024 | $1.4850 |
| 2023 | $1.4300 |
| 2022 | $1.4200 |
Project income from AZN with the AZN dividend calculator or track your full portfolio with the dividend tracker.